Jade Biosciences Inc.

JBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.77

-$0.29 (-2.06%)

Nov 2, 2026, 12:40 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-127.41M	-69.63M	-75.52M	-51.51M	-22.96M	-9.61M
Depreciation & Amortization	26K	282K	96K	68K	15K	1K
Stock-Based Compensation	20.01M	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-8.56M	-9M	9.96M	6.39M	-7.12M	937K
Other Non-Cash Items	20.88M	9.32M	8.85M	4.57M	2.06M	777K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-8.2M	-11.17M	9.8M	7.76M	-6.51M	974K
Operating Cash Flow	-94.69M	-71.2M	-56.78M	-39.12M	-27.4M	-7.86M
Capital Expenditures	-196K	n/a	-142K	-195K	-181K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-261.19M	-19.68M	-123.98M	-147.62M	-113.25M	n/a
Sales Maturities Of Investments	14.42M	75.71M	136M	154.74M	n/a	n/a
Other Investing Acitivies	-31K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-247.01M	56.03M	11.88M	6.93M	-113.43M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	2.5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	171.27M	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	360.77M	25.43M	46M	396K	190.46M	8.92M
Net Cash Flow	19.05M	10.26M	1.09M	-31.8M	49.62M	1.06M
Free Cash Flow	-94.89M	-71.2M	-56.92M	-39.32M	-27.58M	-7.86M
Adj. Free Cash Flow	-114.89M	-71.2M	-56.92M	-39.32M	-27.58M	-7.86M
Maintenance CapEx	-26K	n/a	-96K	-68K	-15K	n/a
Growth CapEx	-170K	n/a	-46K	-127K	-166K	n/a
Owner Earnings	-94.72M	-71.2M	-56.87M	-39.19M	-27.41M	-7.86M